chr16-67646735-A-AG
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_001013838.3(CARMIL2):c.490dup(p.Ala164GlyfsTer4) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
CARMIL2
NM_001013838.3 frameshift
NM_001013838.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.0240
Genes affected
CARMIL2 (HGNC:27089): (capping protein regulator and myosin 1 linker 2) This gene encodes a member of the CARMIL (capping protein, Arp2/3, myosin-I linker) family of proteins. The encoded protein interacts with and negatively regulates the heterodimeric capping protein and promotes cell migration. Reduced expression of this gene has been observed in human psoriasis patients. Mutations in this gene cause a human immunodeficiency syndrome characterized by smooth muscle tumors and impaired T-cell function. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-67646735-A-AG is Pathogenic according to our data. Variant chr16-67646735-A-AG is described in ClinVar as [Pathogenic]. Clinvar id is 266035.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CARMIL2 | NM_001013838.3 | c.490dup | p.Ala164GlyfsTer4 | frameshift_variant | 7/38 | ENST00000334583.11 | NP_001013860.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CARMIL2 | ENST00000334583.11 | c.490dup | p.Ala164GlyfsTer4 | frameshift_variant | 7/38 | 1 | NM_001013838.3 | ENSP00000334958 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Severe combined immunodeficiency due to CARMIL2 deficiency Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2018 | - - |
Combined immunodeficiency Pathogenic:1
Pathogenic, no assertion criteria provided | research | Klein lab, Ludwig-Maximilians-University | Oct 01, 2016 | Experimentally proven primary immunodeficiency; combined immunodeficiency - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at